Links to all GeneRIF Items | 2922 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 12474049 (GRP) | mRNA transcripts are expressed in tumor cells of patients with small cell lung cancer |
| 12820318 (GRP) | ProGRP is a valuable tumour marker for the detection and monitoring of small cell lung cancer (SCLC) and a good tool for discriminating non-small cell lung cancer (NSCLC) versus SCLC |
| 12820319 (GRP) | results show that Pro-GRP may be a potential tumor marker for small cell lung carcinoma |
| 15638385 (GRP) | Measuring serum levels in lung cancer patients may be useful in drug therapy monitoring. |
| 19506400 (GRP) | tumor marker determination, incluidng ProGRP, in patients with suspicious signs of lung cancer suggests, in a few hours, the histological diagnosis in the majority of lung cancer patients. |
| 21529988 (GRP) | serum-positive non-small-cell lung cancers may have neuroendocrine differentiation |
| 24375395 (GRP) | High serum proGRP levels are associated with small-cell lung cancer. |
| 26560853 (GRP) | CEA, NSE, CA125 and pro-GRP could serve as biomarkers for SCLC, and CEA and CYFRA21-1 could serve as biomarkers for NSCLC. Pro-GRP, CA125 and CEA were related to the clinical stages of lung cancer |
| 26886220 (GRP) | High proGRP expression is associated with poor response to chemotherapy in small cell lung cancer. |
| 27639644 (GRP) | pro-gastrin releasing peptide has a role in promoting the cell proliferation and progression in small cell lung cancer |
| 28351312 (GRP) | Our results suggest that, similar to what happens in neutrophils, gastrin-releasing peptide is a migratory, rather than a proliferative, stimulus, for non-small cell lung carcinoma cells, indicating a putative role for gastrin-releasing peptide and gastrin-releasing peptide receptor in metastasis |
| 29145241 (GRP) | serum level not a biomarker in small cell lung cancer |
| 29729229 (GRP) | A panel of three tumor markers CYFRA 21.1, HE4 and ProGRP may play a role for discriminating LC from benign lung disease and subtyping as SCLC. |
| 29989303 (GRP) | ProGRP and NSE serum expression levels predict therapeutic drug response in Chinese lung cancer patients. |
| 30146822 (GRP) | The serum pro-gastrin-releasing peptide (ProGRP) levels were increased in a variety of benign and malignant diseases and were considered a putative marker for small cell lung cancer (SCLC). |
| 31091854 (GRP) | Studied association of progastrin-releasing peptide (proGRP), neuron specific enolase (NSE), chromogranin a (CgA), and squamous cell cancer antigen (SCCA1) in pulmonary neuroendocrine tumor (PNET) and non-small-cell lung carcinoma (NSCLC). Results showed ProGRP can distinguish PNET patients from NSCLC patients, and with adjusted NSE values, it can differentiate the PNET group from the benign disease group. |